Prime Medicine Capital Expenditures (CapEx) Growth & History (PRME)
Prime Medicine's capital expenditures (capex) was $4.5M for fiscal 2025.
View full Prime Medicine company overviewPrime Medicine annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.5M | −$2.8M | −37.88% |
| 2024 | 2024-12-31 | $7.3M | −$1.4M | −16.39% |
| 2023 | 2023-12-31 | $8.7M | −$7.4M | −45.80% |
| 2022 | 2022-12-31 | $16.1M | $11.9M | +287.83% |
| 2021 | 2021-12-31 | $4.2M | $3.5M | +549.45% |
| 2020 | 2020-12-31 | $639,000 | — | — |
Prime Medicine quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $46,000 | −$1.5M | −97.07% |
| Q1 2026 | 2026-03-31 | $214,000 | −$2.2M | −91.16% |
| Q4 2025 | 2025-12-31 | $290,000 | −$1.5M | −83.81% |
| Q3 2025 | 2025-09-30 | $247,000 | −$1.0M | −80.66% |
| Q2 2025 | 2025-06-30 | $1.6M | −$330,000 | −17.35% |
| Q1 2025 | 2025-03-31 | $2.4M | $98,000 | +4.22% |
| Q4 2024 | 2024-12-31 | $1.8M | −$49,000 | −2.66% |
| Q3 2024 | 2024-09-30 | $1.3M | −$1.6M | −56.10% |
| Q2 2024 | 2024-06-30 | $1.9M | −$74,000 | −3.74% |
| Q1 2024 | 2024-03-31 | $2.3M | $325,000 | +16.26% |
| Q4 2023 | 2023-12-31 | $1.8M | −$3.0M | −61.78% |
| Q3 2023 | 2023-09-30 | $2.9M | −$1.9M | −39.28% |
| Q2 2023 | 2023-06-30 | $2.0M | −$2.8M | −58.85% |
| Q1 2023 | 2023-03-31 | $2.0M | $311,000 | +18.42% |
| Q4 2022 | 2022-12-31 | $4.8M | — | — |
| Q3 2022 | 2022-09-30 | $4.8M | — | — |
| Q2 2022 | 2022-06-30 | $4.8M | — | — |
| Q1 2022 | 2022-03-31 | $1.7M | — | — |
Prime Medicine capital expenditures (capex) trends
Over the last five fiscal years, Prime Medicine's capital expenditures (capex) increased from $639,000 to $4.5M, a change of $3.9M. The latest reported quarter, Q2 2026, shows $46,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Prime Medicine source filings ↗